Inflammation Induces TDP-43 Mislocalization and Aggregation
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
TAR DNA-binding protein 43 (TDP-43) is a major component in aggregates of ubiquitinated proteins in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Here we report that lipopolysaccharide (LPS)-induced inflammation can promote TDP-43 mislocalization and aggregation. In culture, microglia and astrocytes exhibited TDP-43 mislocalization after exposure to LPS. Likewise, treatment of the motoneuron-like NSC-34 cells with TNF-alpha (TNF-α) increased the cytoplasmic levels of TDP-43. In addition, the chronic intraperitoneal injection of LPS at a dose of 1mg/kg in TDP-43(A315T) transgenic mice exacerbated the pathological TDP-43 accumulation in the cytoplasm of spinal motor neurons and it enhanced the levels of TDP-43 aggregation. These results suggest that inflammation may contribute to development or exacerbation of TDP-43 proteinopathies in neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, peripheral LPS promotes TDP-43 mislocalization and aggregation, contributing to TDP-43 proteinopathies in neurodegenerative disorders, such as FTLD and ALS.243”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [243]
In the citing paper
“endotoxin promotes TDP-43 aggregation and neuropathology.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
In the citing paper
“Addition of LPS to microglia or astrocytes in culture resulted in TDP-43 mislocalization and aggregation, and addition of peripheral LPS to TDP-43(A315T) transgenic mice resulted in TDP-43 aggregation in vivo [103].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
In the citing paper
“This suggests a dual-hit hypothesis for ALS and FTD: increased endotoxin levels plus aggregable TDP-43 results in neurodegeneration.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 8×
“In summary, the in vitro and in vivo results presented here suggest that inflammation, induced by stimuli of NF-κB signaling such as TNF-α or LPS, may be a mediator of TDP-43 proteinopathy which constitutes a pathological hallmark of ALS and FTLD [4–9].”
BackgroundMethodResultInfluentialArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992 · cited 1×
“We carried out the immunoblots with a widely used polyclonal antibody against TDP-43 [4,5, 8, 6,7, 29, 23], which reacts with both mouse and human TDP-43 species and yields a band at 43 kDa corresponding to the unmodified TDP-43.”
MethodTDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70071-1 · Cited by 723
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Self-citation
Cited by
Items 101–131 of 131
Chaurasia, R., & Ghose, U. (2024) · The Nucleus · doi:10.1007/s13237-024-00465-7 · Cited by 2
Neurotropic Viruses as Acute and Insidious Drivers of Aging
Rocchi, A. R., Wollebo, H. S., & Khalili, K. (2025) · Biomolecules · doi:10.3390/biom15040514 · Cited by 2
Lu, C., & Xu, X. (2023) · Stress and Brain · doi:10.26599/sab.2023.9060002 · Cited by 1
Xia, L., Liu, T., Li, Z., Ao, X., Chen, Q., Zhou, X., Jiang, Q., Huang, N., & Luo, Y. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1741339 · Cited by 1
Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models
Ittner, L. M., Lee, W. S., Stefanoska, K., Asih, P. R., & Ke, Y. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_10 · Cited by 1
Dance and Resistance: An Embodiment of the Body as a Medium to Fight Violence against Women
Tendenan, V. M. R. M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109681 · Cited by 1
Relevancia del receptor cannabinoide cb2 en la esclerosis lateral amiotrófica (ela)
Espejo‐Porras, F. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Molecular pathomechanisms of Amyotrophic Lateral Sclerosis caused by FUS mutations
An, H. (2019) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Bhopatkar, A. A., Dhakal, S., & Rangachari, V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.25.449959 · Cited by 1
Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models
van Eersel, J., Delerue, F., Ittner, L. M., & Ke, Y. D. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6380-0_8
Zeineddine, R. (2016) · Research Online (University of Wollongong)
Thammisetty, S. S. (2018) · Corpus Université Laval (Université Laval)
Molecular mechanisms of neurodegeneration in neurodegenerative diseases
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821711-5.00004-8
A Vitamin Treatment for Motor Neurone Disease
Baptie, A., & McCaffery, P. J. A. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_14
Tamura, R., Taguchi, R., Yamada, T., Wada, H., Ayaki, T., Takahashi, R., & Urushitani, M. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578779
Exploring cellular toxicity mechanisms and immunotherapeutic potential of TDP-43 in ALS/FTD
Riemenschneider, H. (2024) · doi:10.5282/edoc.34109
Modelling diseases associated with mitochondrial proteins CHCHD10 and CHCHD2 in zebrafish
Légaré, V. P. (2023) · eScholarship@McGill (McGill) · doi:10.82308/18390
Sieben, A. (2021) · Ghent University Academic Bibliography (Ghent University)
TDP-43 protein - role in disease and normal aging
Salo, I. (2025) · Tampere University Institutional Repository (Tampere University)
Berriat, F. (2022) · theses.fr (ABES) · doi:10.70675/ae816e5az90a6z453dza37ez26fd09d1f48c
Picard, F. (2024) · theses.fr (ABES) · doi:10.70675/4a7f60caz630dz45d7z869fzc4b0454fc792
Carboplatin alleviates astrocytic TDP-43 neurotoxicity by inhibiting NF-κB activation
Song, J., Lee, S., Lee, J., Gil, Y., Kim, T., Kim, S.-Y., Cha, S.-J., Kim, H.-J., & Kim, K. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178968
Vézina, A., Paquet, A., Blais, M., Gros‐Louis, F., Picher‐Martel, V., & Dupré, N. (2026) · Contemporary clinical neuroscience · doi:10.1007/978-3-032-18296-8_20
Nanotherapeutics targeting neuroinflammation
Chaulagain, B., Tagoe, B., Gothwal, A., Mahanta, A. K., Muolokwu, C. E., Lamsal, B., & Singh, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00013-1
Pan, M. L. (2023) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
MICROBIOTA AND AMYOTROPHIC LATERAL SCLEROSIS: DYSBIOSIS, METABOLITES, AND EMERGING THERAPIES
Coello, A. J. L., Villegas, C. D. S., Coello, K. P. L., Songor, F. D. Q., Leon, P. C. M., Guerra, D. S. I., Soto, S. N. H., & Miñaca, S. A. M. (2026) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v12i7.28853
ALS/FTD-linked TDP-43 alterations prevent HSV-1 infection by disrupting cell-adhesion pathwaysPreprint
Jackvony, S., Ijaz, L., Hardin, E. J., Aikedan, A., Zhou, C. Q., Yadavalli, T., Jang, M. W., Mahoney, M., Gan, L., Shukla, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.28.755069
Zhou, D., Yan, H., Yang, S., Zhang, Y., Xu, X., Cen, X., Lei, K., & Xia, H. (2021) · doi:10.3389/fphar.2021.741219.s002
Metadata
- Authors
- Correia, A. S., Patel, P., Dutta, K., & Julien, J.-P.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- Institut Universitaire en Santé Mentale de Québec (CA)
- Corresponding author
- Julien, Jean-Pierre
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 10
- Issue
- 10
- Pages
- e0140248
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4596857
- OpenAlex
- W1621668151
- Cited by
- 114
- References
- 39
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 10 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 6
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- TDP-43, protein aggregation, mislocalization, neuroinflammation, lipopolysaccharide, microglia, astrocytes, TNF-α, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, motor neurons, neurodegeneration
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Humans, Inflammation, Lipopolysaccharides, Mice, Transgenic, RNA, Messenger, Point Mutation, Microglia, Mice, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.